Main > ONCOLOGY (**) > Breast Cancer>HR+>HER2+>MET>PM * > Treatment > CH. N. Lapatinib+Letrozole>



CH. N. Lapatinib+Letrozole>'s subsections
>Companion Diagnostics>
>Hormonal Therapy is Indicated
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2008. 11.11
TradeMark
TradeMark Web-Site

CH. N. Lapatinib+Letrozole>'s products
This section has no products